1.
The Characteristic Research of Fibrinolytic Factors in Pcos;
多囊卵巢综合征纤溶因子的特征研究
2.
The Differential Diagnostic Value of Major Fibrinolytic Parameters in Pleural Fluid
胸腔积液中纤溶因子的检测及其临床意义
3.
Clinical and Experimental Study of Effect of Continuous Blood Purification on Thrombotic and Fibrinolytic Factors and Mechanism;
连续性血液净化对凝血纤溶因子影响及其机制的临床与实验研究
4.
In Silico Cloning of Component F-I-0 Gene of Earthworm Fibrinolytic Enzymes;
蚯蚓纤溶酶F-I-0基因的电子克隆
5.
Expression of Plasminogen Activator、Plasminogen Activator Inhibitor in Polycystic Ovary Syndrome
纤溶酶原激活、抑制因子在PCOS卵巢中的表达
6.
The Study on Relationship between the Expression of Plasminogen Activator, Plasminogen Activator Inhibitors and Invasion and Metastasis in Ovarian Carcinoma;
纤溶酶原激活因子及其抑制因子与卵巢癌的浸润转移
7.
The expression of plasminogen activator inhibitor 1 (PAI 1) gene in human astrocytomasG
人脑星形细胞瘤纤溶酶原激活抑制因子1基因表达研究
8.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
9.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
10.
Effects of caesarean section on neonate umbilical cord blood plasmin and immunologic factors
选择性剖宫产对新生儿脐血纤溶酶活性及免疫因子的影响
11.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
12.
Investigation of Soluble TNF-α Receptor to Silica Induced Pulmonary Fibrosis in Rats;
肿瘤坏死因子-α可溶性受体对矽肺纤维化的干预研究
13.
The Correlation between Plasma Level of Inflammatory Cytokines and Fibrinolytic Capacity in Patients with Acute Coronary Syndrome
急性冠脉综合征患者纤溶活性与炎症因子的关系
14.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
15.
Soluble Expression of Recombinant Human Fibroblast Growth Factor-8a in Escherichia coli
重组人成纤维细胞生长因子-8a在大肠杆菌中的可溶性表达
16.
Association of plasminogen activator inhibitor-1 gene promoter 4G/5G genotype polymorphism with gestational diabetes
纤溶酶原激活物抑制因子1基因启动子区4G/5G多态性与妊娠糖尿病的相关性研究
17.
The Changes of the Plasiminogen Activitor Inhibitor-1(PAI-1) in Patients with Coronary Heart Desease and It s Relationship to Clinical Factors;
冠心病患者血浆纤溶酶原激活剂抑制因子（PAI-1）的变化及其相关因素的研究
18.
Study of the Urokinase-type Plasminogen Activator Inhibited by Triplex-Forming Oligonucleotides in Rat Sertoli Cells;
三链形成寡核苷酸对大鼠Sertoli细胞尿激酶型纤溶酶原激活因子的反基因研究